Beta-1,4-Galactosyltransferase 1 (B4GALT1) Antibody

273€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Beta-1,4-Galactosyltransferase 1 (B4GALT1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx175564
tested applications
WB, IHC, IF/ICC
Description
Beta-1,4-Galactosyltransferase 1 (b4GALT1) Antibody is a Rabbit Polyclonal antibody against Beta-1,4-Galactosyltransferase 1 (b4GALT1).
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Beta-1,4-Galactosyltransferase 1 (B4GALT1) |
Host | Rabbit |
Reactivity | Human |
Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
Size 1 | 100 µl |
Size 2 | 200 µl |
Size 3 | 1 ml |
Form | Liquid |
Tested Applications | WB, IHC, IF/ICC |
Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
Availability | Shipped within 5-7 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Background | Antibody anti-B4GALT1 |
Status | RUO |
Descripción
Related Products

Recombinant Human B4GALT1
Ver Producto
Beta-1,4-Galactosyltransferase 1 (B4GALT1) Antibody
Rabbit polyclonal antibody against B4GALT1 protein. Immunogen region is C-terminal.
Ver Producto
Beta-1,4-Galactosyltransferase 1 (B4GALT1) Antibody
B4GalT1 is an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing.
Ver Producto